Physician profile
Justina James
NPI 1578220505
$966.18
in general payments reported to CMS, 2019-2025
13 companies · $966 in 2025
The $966 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $314.08 | 2025 | Dupixent, Libtayo |
| Arcutis Biotherapeutics, INC. | $147.14 | 2025 | Zoryve |
| Genzyme Corporation | $144.86 | 2025 | |
| Janssen Biotech, INC. | $108.97 | 2025 | Tremfya, Stelara, Simponi |
| Amgen INC. | $40.82 | 2025 | Otezla |
| Mayne Pharma Commercial LLC | $39.32 | 2025 | |
| Ucb, INC. | $37.57 | 2025 | Bimzelx |
| Convatec INC. | $36.77 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $26.45 | 2025 | Sotyktu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.87 | 2025 | Spevigo |
| Ani Pharmaceuticals, INC. | $18.76 | 2025 | Veregen |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.83 | 2025 | Siliq, Jublia, Cabtreo |
| Journey Medical Corporation | $15.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justina James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.